Jie Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jie Li has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Fanxin Zeng
Department of Clinical Research Center, Dazhou Central Hospital and Institute of Basic Medicine and Forensic Medicine, North Sichuan Medical College, Nanchong, China
2 shared publications - Jiangping Fu
Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Southwest Medical University, China
2 shared publications Zhaoping Zeng
Department of Clinical Research Center, Dazhou Central Hospital, Dazhou, Sichuan, China
2 shared publications- Benjin Zhang
Department of Pediatrics, Dazhou Central Hospital, Dazhou, China
1 shared publication - Chaoqiang Zheng
Department of Clinical Laboratory, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou 350014, China
1 shared publication - Fang Wu
Department of Radiation Oncology, The First Affiliated Hospital of Guangxi Medical University, China
1 shared publication
Latest Publications
- Open Access
- 10 August 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1797826
Physical activity, sedentary behavior, and metabolic-reproductive health in women with PMOS (PCOS): a narrative review of mechanisms, clinical evidence, and individualized intervention strategies
Polyendocrine Metabolic Ovarian Syndrome (PMOS) is a common endocrine-metabolic disorder in reproductive-aged women, characterized by clinical heterogeneity and an increased susceptibility to insulin resistance, type 2 diabetes mellitus, dyslipidemia, non-alcoholic fatty liver disease, and cardiometabolic risk. Although PMOS is often recognized through reproductive manifestations such as menstrual irregularity, ovulatory dysfunction, hyperandrogenism, and infertility, metabolic dysfunction is closely linked to reproductive outcomes through effects on androgen excess, ovulatory function, oocyte competence, and the intrauterine metabolic environment. Physical activity, structured exercise, and sedentary behavior are modifiable lifestyle factors that may influence both metabolic and reproductive health in PMOS. This narrative review synthesizes current evidence on the associations among physical activity, sedentary behavior, and metabolic complications in women with PMOS. We summarize interconnected mechanisms involving insulin signaling, adipose tissue dysfunction, chronic low-grade inflammation, oxidative stress, mitochondrial function, and gut microbiota in women with PMOS, while distinguishing evidence from observational studies, clinical intervention trials, and mechanistic or preclinical research. We also review clinical evidence on exercise modalities, including aerobic exercise, resistance training, combined training, and high-intensity interval training, as well as emerging strategies to reduce or interrupt prolonged sedentary time. Available evidence supports physical activity and structured exercise as important components of PMOS management, particularly for improving insulin sensitivity, body composition, cardiometabolic risk markers, and, in some studies, menstrual cyclicity and ovulatory function. However, findings vary according to baseline BMI, hyperandrogenic phenotype, intervention type, intensity, duration, adherence, and co-interventions such as diet or pharmacotherapy. Evidence regarding sedentary behavior remains more limited and is largely observational. Therefore, causal interpretations should be made cautiously. Finally, this review discusses individualized, patient-centered intervention strategies and identifies research gaps, including long-term randomized controlled trials, reproductive and cardiometabolic hard outcomes, combined lifestyle-pharmacological approaches, and precision medicine frameworks for women with PMOS.
- 10 August 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1797826
Open AccessPhysical activity, sedentary behavior, and metabolic-reproductive health in women with PMOS (PCOS): a narrative review of mechanisms, clinical evidence, and individualized intervention strategies
Polyendocrine Metabolic Ovarian Syndrome (PMOS) is a common endocrine-metabolic disorder in reproductive-aged women, characterized by clinical heterogeneity and an increased susceptibility to insulin resistance, type 2 diabetes mellitus, dyslipidemia, non-alcoholic fatty liver disease, and cardiometabolic risk. Although PMOS is often recognized through reproductive manifestations such as menstrual irregularity, ovulatory dysfunction, hyperandrogenism, and infertility, metabolic dysfunction is closely linked to reproductive outcomes through effects on androgen excess, ovulatory function, oocyte competence, and the intrauterine metabolic environment. Physical activity, structured exercise, and sedentary behavior are modifiable lifestyle factors that may influence both metabolic and reproductive health in PMOS. This narrative review synthesizes current evidence on the associations among physical activity, sedentary behavior, and metabolic complications in women with PMOS. We summarize interconnected mechanisms involving insulin signaling, adipose tissue dysfunction, chronic low-grade inflammation, oxidative stress, mitochondrial function, and gut microbiota in women with PMOS, while distinguishing evidence from observational studies, clinical intervention trials, and mechanistic or preclinical research. We also review clinical evidence on exercise modalities, including aerobic exercise, resistance training, combined training, and high-intensity interval training, as well as emerging strategies to reduce or interrupt prolonged sedentary time. Available evidence supports physical activity and structured exercise as important components of PMOS management, particularly for improving insulin sensitivity, body composition, cardiometabolic risk markers, and, in some studies, menstrual cyclicity and ovulatory function. However, findings vary according to baseline BMI, hyperandrogenic phenotype, intervention type, intensity, duration, adherence, and co-interventions such as diet or pharmacotherapy. Evidence regarding sedentary behavior remains more limited and is largely observational. Therefore, causal interpretations should be made cautiously. Finally, this review discusses individualized, patient-centered intervention strategies and identifies research gaps, including long-term randomized controlled trials, reproductive and cardiometabolic hard outcomes, combined lifestyle-pharmacological approaches, and precision medicine frameworks for women with PMOS.
- Open Access
- 1 April 2025
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 14 (4) , 2457-2469
Role of TRKC and NT-3 proteins in the progression and prognosis of colorectal cancer
Background: Colorectal cancer (CRC) is a common tumor of the digestive system. In recent years, CRC has had the fourth highest incidence and second highest mortality rate among tumors worldwide. Therefore, it is important to identify new molecular markers, and examine their relationship with the clinicopathological features and prognosis of CRC patients. This study examined the correlation between the expression levels of the tropomyosin receptor kinase C (TRKC) and neurotrophic factor-3 (NT-3) proteins, and the clinicopathological features and prognosis of CRC patients. Methods: In total, 141 paraffin-embedded specimens from patients who had undergone radical surgical resection for CRC were analyzed. All CRC diagnoses were confirmed by pathological examination. Corresponding adjacent normal tissues served as controls. Immunohistochemical staining was employed to assess the expression of the TRKC and NT-3 proteins in both the CRC and adjacent normal tissues. A subsequent statistical analysis was conducted to explore the associations between the expression levels of these proteins, and the clinicopathological features and prognostic outcomes of CRC patients. Results: The expression level of TRKC was significantly higher in the CRC tissues than the adjacent normal tissues, while the expression level of NT-3 was significantly lower in the CRC tissues than the adjacent normal tissues, and the observed differences were statistically significant (PTRKC expression was significantly correlated with the tumor site (PTRKC had significantly shorter overall survival (OS) and progression-free survival (PFS) times than those with negative TRKC expression (PNT-3 expression was significantly associated with lymph node metastasis (PNT-3 expression had prolonged OS and PFS compared to those with negative NT-3 expression (PTRKC expression had a hazard ratio (HR) of 2.679 (PNT-3 expression had a HR of 0.433 (PConclusions: We found that the TRKC and NT-3 proteins were closely associated with the occurrence, metastasis, invasion, and tumor marker levels of CRC, and can be used as independent predictors of prognosis in patients with CRC. TRKC mainly indicates a poor prognosis in CRC, while NT-3 indicates a good prognosis.
- 1 April 2025
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 14 (4) , 2457-2469
Open AccessRole of TRKC and NT-3 proteins in the progression and prognosis of colorectal cancer
Background: Colorectal cancer (CRC) is a common tumor of the digestive system. In recent years, CRC has had the fourth highest incidence and second highest mortality rate among tumors worldwide. Therefore, it is important to identify new molecular markers, and examine their relationship with the clinicopathological features and prognosis of CRC patients. This study examined the correlation between the expression levels of the tropomyosin receptor kinase C (TRKC) and neurotrophic factor-3 (NT-3) proteins, and the clinicopathological features and prognosis of CRC patients. Methods: In total, 141 paraffin-embedded specimens from patients who had undergone radical surgical resection for CRC were analyzed. All CRC diagnoses were confirmed by pathological examination. Corresponding adjacent normal tissues served as controls. Immunohistochemical staining was employed to assess the expression of the TRKC and NT-3 proteins in both the CRC and adjacent normal tissues. A subsequent statistical analysis was conducted to explore the associations between the expression levels of these proteins, and the clinicopathological features and prognostic outcomes of CRC patients. Results: The expression level of TRKC was significantly higher in the CRC tissues than the adjacent normal tissues, while the expression level of NT-3 was significantly lower in the CRC tissues than the adjacent normal tissues, and the observed differences were statistically significant (PTRKC expression was significantly correlated with the tumor site (PTRKC had significantly shorter overall survival (OS) and progression-free survival (PFS) times than those with negative TRKC expression (PNT-3 expression was significantly associated with lymph node metastasis (PNT-3 expression had prolonged OS and PFS compared to those with negative NT-3 expression (PTRKC expression had a hazard ratio (HR) of 2.679 (PNT-3 expression had a HR of 0.433 (PConclusions: We found that the TRKC and NT-3 proteins were closely associated with the occurrence, metastasis, invasion, and tumor marker levels of CRC, and can be used as independent predictors of prognosis in patients with CRC. TRKC mainly indicates a poor prognosis in CRC, while NT-3 indicates a good prognosis.
- Open Access
- 30 August 2024
- Published by Springer Nature in Discover Oncology
- Vol. 15 (1) , 1-20
Construction and analysis of a lysosome-dependent cell death score-based prediction model for non-small cell lung cancer
Background Non-small cell lung cancer (NSCLC) is the most common type of tumor globally and the leading cause of cancer-related deaths. Although treatment strategies such as immune checkpoint inhibitors and chemotherapy have advanced, the heterogeneity among NSCLC patients results in significant variability in treatment outcomes. Studies have shown that certain patients respond poorly to immune checkpoint inhibitors, indicating that treatment response is closely related to multiple factors. Therefore, it is necessary to develop predictive models to stratify patients based on gene expression and clinical characteristics, aiming for precision therapy. Objective This study aims to construct a stratified prognostic model for NSCLC patients based on lysosome-dependent cell death (LDCD) scoring by integrating single-cell RNA sequencing (scRNA-seq) and bulk RNA sequencing data. By analyzing the immune-related characteristics of high-risk and low-risk groups, we further explored the impact of cell death patterns on lung cancer and identified potential therapeutic targets. Methods This study obtained single-cell RNA sequencing data and gene expression data of NSCLC patients and normal lung tissues from the GEO and TCGA databases. We used R packages such as Seurat and CellChat for data preprocessing and analysis, and performed dimensionality reduction and visualization through Principal Component Analysis (PCA) and UMAP algorithms. LASSO regression analysis was used to construct the predictive model, followed by cross-validation and ROC curve analysis. The model’s effectiveness was validated through survival analysis and immune microenvironment analysis. Results The study showed a significant increase in the proportion of monocytes in NSCLC tissues, suggesting their important role in cancer progression. Cell communication analysis indicated that macrophages, smooth muscle cells, and myeloid cells exhibit strong intercellular communication during cancer progression. Using the constructed prognostic model based on 12 LDCD-related genes, we found significant differences in overall survival and immune microenvironment between the high-risk and low-risk groups.
- 30 August 2024
- Published by Springer Nature in Discover Oncology
- Vol. 15 (1) , 1-20
Open AccessConstruction and analysis of a lysosome-dependent cell death score-based prediction model for non-small cell lung cancer
Background Non-small cell lung cancer (NSCLC) is the most common type of tumor globally and the leading cause of cancer-related deaths. Although treatment strategies such as immune checkpoint inhibitors and chemotherapy have advanced, the heterogeneity among NSCLC patients results in significant variability in treatment outcomes. Studies have shown that certain patients respond poorly to immune checkpoint inhibitors, indicating that treatment response is closely related to multiple factors. Therefore, it is necessary to develop predictive models to stratify patients based on gene expression and clinical characteristics, aiming for precision therapy. Objective This study aims to construct a stratified prognostic model for NSCLC patients based on lysosome-dependent cell death (LDCD) scoring by integrating single-cell RNA sequencing (scRNA-seq) and bulk RNA sequencing data. By analyzing the immune-related characteristics of high-risk and low-risk groups, we further explored the impact of cell death patterns on lung cancer and identified potential therapeutic targets. Methods This study obtained single-cell RNA sequencing data and gene expression data of NSCLC patients and normal lung tissues from the GEO and TCGA databases. We used R packages such as Seurat and CellChat for data preprocessing and analysis, and performed dimensionality reduction and visualization through Principal Component Analysis (PCA) and UMAP algorithms. LASSO regression analysis was used to construct the predictive model, followed by cross-validation and ROC curve analysis. The model’s effectiveness was validated through survival analysis and immune microenvironment analysis. Results The study showed a significant increase in the proportion of monocytes in NSCLC tissues, suggesting their important role in cancer progression. Cell communication analysis indicated that macrophages, smooth muscle cells, and myeloid cells exhibit strong intercellular communication during cancer progression. Using the constructed prognostic model based on 12 LDCD-related genes, we found significant differences in overall survival and immune microenvironment between the high-risk and low-risk groups.
- Open Access
- 17 June 2023
- Published by Springer Nature in BMC Pediatrics
- Vol. 23 (1) , 1-8
Development of a blood proteins-based model for bronchopulmonary dysplasia prediction in premature infants
Background: Bronchopulmonary dysplasia (BPD) is the most common chronic pulmonary disease in premature infants. Blood proteins may be early predictors of the development of this disease.Methods: In this study, protein expression profiles (blood samples during their first week of life) and clinical data of the GSE121097 was downloaded from the Gene Expression Omnibus. Weighted gene co-expression network analysis (WGCNA) and differential protein analysis were carried out for variable dimensionality reduction and feature selection. Least absolute shrinkage and selection operator (LASSO) were conducted for BPD prediction model development. The performance of the model was evaluated by the receiver operating characteristic (ROC) curve, calibration curve, and decision curve.Results: The results showed that black module, magenta module and turquoise module, which included 270 proteins, were significantly correlated with the occurrence of BPD. 59 proteins overlapped between differential analysis results and above three modules. These proteins were significantly enriched in 253 GO terms and 11 KEGG signaling pathways. Then, 59 proteins were reduced to 8 proteins by LASSO analysis in the training cohort. The proteins model showed good BPD predictive performance, with an AUC of 1.00 (95% CI 0.99-1.00) and 0.96 (95% CI 0.90-1.00) in training cohort and test cohort, respectively.Conclusion: Our study established a reliable blood-protein based model for early prediction of BPD in premature infants. This may help elucidate pathways to target in lessening the burden or severity of BPD.
- 17 June 2023
- Published by Springer Nature in BMC Pediatrics
- Vol. 23 (1) , 1-8
Open AccessDevelopment of a blood proteins-based model for bronchopulmonary dysplasia prediction in premature infants
Background: Bronchopulmonary dysplasia (BPD) is the most common chronic pulmonary disease in premature infants. Blood proteins may be early predictors of the development of this disease.Methods: In this study, protein expression profiles (blood samples during their first week of life) and clinical data of the GSE121097 was downloaded from the Gene Expression Omnibus. Weighted gene co-expression network analysis (WGCNA) and differential protein analysis were carried out for variable dimensionality reduction and feature selection. Least absolute shrinkage and selection operator (LASSO) were conducted for BPD prediction model development. The performance of the model was evaluated by the receiver operating characteristic (ROC) curve, calibration curve, and decision curve.Results: The results showed that black module, magenta module and turquoise module, which included 270 proteins, were significantly correlated with the occurrence of BPD. 59 proteins overlapped between differential analysis results and above three modules. These proteins were significantly enriched in 253 GO terms and 11 KEGG signaling pathways. Then, 59 proteins were reduced to 8 proteins by LASSO analysis in the training cohort. The proteins model showed good BPD predictive performance, with an AUC of 1.00 (95% CI 0.99-1.00) and 0.96 (95% CI 0.90-1.00) in training cohort and test cohort, respectively.Conclusion: Our study established a reliable blood-protein based model for early prediction of BPD in premature infants. This may help elucidate pathways to target in lessening the burden or severity of BPD.
- Open Access
- 2 February 2023
- Published by MDPI AG in Current Oncology
- Vol. 30 (2) , 1818-1830
Altered Gut Microbiota Composition and Its Potential Association in Patients with Advanced Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the second-most-common cause of cancer death. In recent years, studies have suggested that intestinal microbiota dysregulation is closely related to HCC and can affect the therapeutic efficacy of immune checkpoint inhibitors. However, there are few data on the relationship between altered gut microbiota composition and its potential association in patients with advanced hepatocellular carcinoma. Hence, in this study, we aimed to investigate the gut microbiota profile associated with advanced hepatocarcinoma. In total, 20 patients with advanced hepatocarcinoma and 20 matched healthy participants were recruited. Stool samples were collected for 16S rRNA sequencing to confirm intestinal microbiota dysbiosis. The results showed that the Nseqs index in advanced hepatocarcinoma patients was significantly different compared with that in healthy individuals, while the butyrate-producing bacteria decreased and LPS-producing bacteria increased. Meanwhile, Lactobacillus, Anaerostipes, Fusicatenibacter, Bifidobacterium, and Faecalibacterium were significantly correlated with AFP, ALT, AST, and PIVKA. Our findings characterized the gut microbiota composition of advanced hepatocarcinoma, providing an experimental basis and theoretical support for using microbiota to regulate immunotherapy, achieve potential biomarkers for diagnosis, and improve the effect of clinical treatment for patients with advanced hepatocarcinoma.
- 2 February 2023
- Published by MDPI AG in Current Oncology
- Vol. 30 (2) , 1818-1830
Open AccessAltered Gut Microbiota Composition and Its Potential Association in Patients with Advanced Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the second-most-common cause of cancer death. In recent years, studies have suggested that intestinal microbiota dysregulation is closely related to HCC and can affect the therapeutic efficacy of immune checkpoint inhibitors. However, there are few data on the relationship between altered gut microbiota composition and its potential association in patients with advanced hepatocellular carcinoma. Hence, in this study, we aimed to investigate the gut microbiota profile associated with advanced hepatocarcinoma. In total, 20 patients with advanced hepatocarcinoma and 20 matched healthy participants were recruited. Stool samples were collected for 16S rRNA sequencing to confirm intestinal microbiota dysbiosis. The results showed that the Nseqs index in advanced hepatocarcinoma patients was significantly different compared with that in healthy individuals, while the butyrate-producing bacteria decreased and LPS-producing bacteria increased. Meanwhile, Lactobacillus, Anaerostipes, Fusicatenibacter, Bifidobacterium, and Faecalibacterium were significantly correlated with AFP, ALT, AST, and PIVKA. Our findings characterized the gut microbiota composition of advanced hepatocarcinoma, providing an experimental basis and theoretical support for using microbiota to regulate immunotherapy, achieve potential biomarkers for diagnosis, and improve the effect of clinical treatment for patients with advanced hepatocarcinoma.
- Open Access
A model of multiple tumor marker for lymph node metastasis assessment in colorectal cancer: a retrospective study
Background: Assessment of colorectal cancer (CRC) lymph node metastasis (LNM) is critical to the decision of surgery, prognosis, and therapy strategy. In this study, we aimed to develop and validate a multiple tumor marker nomogram for predicting LNM in CRC patients. Methods: A total of 674 patients who met the inclusion criteria were collected and randomly divided into primary cohort and internal test cohort at a ratio of 7:3. An external test cohort enrolled 178 CRC patients from the West China Hospital. Clinicopathologic variables were obtained from electronic medical records. The least absolute shrinkage and selection operator (LASSO) and interquartile range analysis were carried out for variable dimensionality reduction and feature selection. Multivariate logistic regression analysis was conducted to develop predictive models of LNM. The performance of the established models was evaluated by the receiver operating characteristic (ROC) curve, calibration belt, and clinical usefulness. Results: Based on minimum criteria, 18 potential features were reduced to six predictors by LASSO and interquartile range in the primary cohort. The model demonstrated good discrimination and ROC curve (AUC = 0.721 in the internal test cohort, AUC = 0.758 in the external test cohort) in LNM assessment. Good calibration was shown for the probability of CRC LNM in the internal and external test cohorts. Decision curve analysis illustrated that multi-tumor markers nomogram was clinically useful. Conclusions: The study proposed a reliable nomogram that could be efficiently and conveniently utilized to facilitate the assessment of individually-tailored LNM in patients with CRC, complementing imaging and biopsy tests.
Open AccessA model of multiple tumor marker for lymph node metastasis assessment in colorectal cancer: a retrospective study
Background: Assessment of colorectal cancer (CRC) lymph node metastasis (LNM) is critical to the decision of surgery, prognosis, and therapy strategy. In this study, we aimed to develop and validate a multiple tumor marker nomogram for predicting LNM in CRC patients. Methods: A total of 674 patients who met the inclusion criteria were collected and randomly divided into primary cohort and internal test cohort at a ratio of 7:3. An external test cohort enrolled 178 CRC patients from the West China Hospital. Clinicopathologic variables were obtained from electronic medical records. The least absolute shrinkage and selection operator (LASSO) and interquartile range analysis were carried out for variable dimensionality reduction and feature selection. Multivariate logistic regression analysis was conducted to develop predictive models of LNM. The performance of the established models was evaluated by the receiver operating characteristic (ROC) curve, calibration belt, and clinical usefulness. Results: Based on minimum criteria, 18 potential features were reduced to six predictors by LASSO and interquartile range in the primary cohort. The model demonstrated good discrimination and ROC curve (AUC = 0.721 in the internal test cohort, AUC = 0.758 in the external test cohort) in LNM assessment. Good calibration was shown for the probability of CRC LNM in the internal and external test cohorts. Decision curve analysis illustrated that multi-tumor markers nomogram was clinically useful. Conclusions: The study proposed a reliable nomogram that could be efficiently and conveniently utilized to facilitate the assessment of individually-tailored LNM in patients with CRC, complementing imaging and biopsy tests.
- Open Access
Epidemiological and Clinical Characteristics of 17 Hospitalized Patients with 2019 Novel Coronavirus Infections Outside Wuhan, China
SUMMARY: An increasing number of cases of novel coronavirus pneumonia (NCP) infected with 2019-nCoV have been identified in Wuhan and other cities in China, since December 2019. We analyzed data on the 17 confirmed cases in Dazhou to provide the epidemiologic characteristics of NCP outside Wuhan. Among them, 12 patients were still quarantined in the hospital, 5 patients were discharged NCP patients according to the national standards. Compared with non-discharged NCP patients, the discharged NCP patients had younger ages. Moreover, discharged NCP patients had higher heart rate, lymphocytes levels and monocytes levels than non-discharged NCP patients on admission to the hospital. Notably, all of 17 patients had abnormal increased C-reactive protein levels, and 16 patients had abnormal computed tomography images. This study provided some information that younger age, higher lymphocytes levels and monocytes levels at the diagnoses of 2019-nCoV may contributed to faster recovery and better therapeutic outcome.
Open AccessEpidemiological and Clinical Characteristics of 17 Hospitalized Patients with 2019 Novel Coronavirus Infections Outside Wuhan, China
SUMMARY: An increasing number of cases of novel coronavirus pneumonia (NCP) infected with 2019-nCoV have been identified in Wuhan and other cities in China, since December 2019. We analyzed data on the 17 confirmed cases in Dazhou to provide the epidemiologic characteristics of NCP outside Wuhan. Among them, 12 patients were still quarantined in the hospital, 5 patients were discharged NCP patients according to the national standards. Compared with non-discharged NCP patients, the discharged NCP patients had younger ages. Moreover, discharged NCP patients had higher heart rate, lymphocytes levels and monocytes levels than non-discharged NCP patients on admission to the hospital. Notably, all of 17 patients had abnormal increased C-reactive protein levels, and 16 patients had abnormal computed tomography images. This study provided some information that younger age, higher lymphocytes levels and monocytes levels at the diagnoses of 2019-nCoV may contributed to faster recovery and better therapeutic outcome.